+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
ID07759154

Evaluating the Effects of Centanafadine Extended-Release Capsules Taken Once Daily in Adults With ADHD and Emotional Dysregulation

Led by Otsuka Pharmaceutical Development & Commercialization, Inc. · Updated on 2026-09-14

80

Participants Needed

16

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness of centanafadine extended-release capsules taken once daily in adults who have attention-deficithyperactivity disorder ADHD along with emotional dysregulation ED. This Phase 3b, open-label study aims to understand how this treatment may affect symptoms of ADHD and emotional regulation in this population. The trial is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc. and includes adults aged 18 to 65 years. Participants in this study will receive centanafadine XR capsules at a dose of 328.8 milligrams orally once daily for eight weeks. This single-group trial does not include a placebo or comparator group. The treatment period lasts for eight weeks, during which participants take the study drug daily to assess its effects on ADHD and emotional dysregulation symptoms. During the study, participants will be monitored through various assessments including the Wender-Reimherr Adult Attention Deficit Disorder Scale WRAADDS, Clinical Global Impressions for ADHD severity, executive function evaluations, and emotional regulation scales. Safety is also monitored by tracking adverse events and suicidal ideation or behavior. The main outcome measure assesses changes in ADHD symptoms over the eight-week treatment period, with study participation lasting approximately two months.

CONDITIONS

Brief Title

A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation

Research Team

O

Otsuka Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here